<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Although the majority of sudden <z:hpo ids='HP_0001695'>cardiac arrests</z:hpo> occur in patients with <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, the effect of therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> susceptibility during <z:hpo ids='HP_0011009'>acute</z:hpo> global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is not well understood </plain></SENT>
<SENT sid="1" pm="."><plain>While both <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and severe <z:hpo ids='HP_0002045'>hypothermia</z:hpo> are arrhythmogenic, patients undergoing therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> do not have an increase in <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, despite the fact that most sudden <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> occur in the setting of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> induced prior to <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> and reperfusion will have a beneficial effect on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-related <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> substrates </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: We developed a model of global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion in the canine wedge preparation to study the transmural electrophysiologic effects of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> at different temperatures </plain></SENT>
<SENT sid="4" pm="."><plain>SETTING: Animal study </plain></SENT>
<SENT sid="5" pm="."><plain>SUBJECTS: Male mongrel dogs </plain></SENT>
<SENT sid="6" pm="."><plain>INTERVENTIONS: Canine left ventricle wedge preparations at 1) control (36°C) or 2) mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, to simulate temperatures used in therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (32°C), were subjected to 15 mins of no-flow <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and subsequently reperfused </plain></SENT>
<SENT sid="7" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: Optical action potentials were recorded spanning the transmural wall of left ventricle </plain></SENT>
<SENT sid="8" pm="."><plain>Action potential duration for epicardial, mid-myocardial, and epicardial cells was measured </plain></SENT>
<SENT sid="9" pm="."><plain>Transmural dispersion of repolarization and conduction velocity were measured at baseline, during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and during reperfusion </plain></SENT>
<SENT sid="10" pm="."><plain>No difference was seen at baseline for conduction velocity or dispersion of repolarization between groups </plain></SENT>
<SENT sid="11" pm="."><plain>Conduction velocity decreased from 0.46 ± 0.02 m/sec to 0.23 ± 0.07 m/sec, and dispersion of repolarization increased from 30 ± 5 msecs to 57 ± 4 msecs in the control group at 15 mins of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> attenuated both the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced conduction velocity slowing (decreasing from 0.44 ± 0.02 m/sec to 0.35 ± 0.03 m/sec; p = .019) and the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in dispersion of repolarization (25 ± 3 msecs to 37 ± 7 msecs; p = .037) </plain></SENT>
<SENT sid="13" pm="."><plain>Epicardial conduction block was observed in six of seven preparations of the control group, but no preparations in the mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> group developed conduction block (0/6) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: Mild <z:hpo ids='HP_0002045'>hypothermia</z:hpo> attenuated <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in dispersion of repolarization, conduction slowing, and block, which are known mechanisms of arrhythmogenesis in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>These data suggest that therapeutic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> may decrease arrhythmogenesis during <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> </plain></SENT>
</text></document>